Page last updated: 2024-11-05

5-methylurapidil and Hypertension, Pulmonary

5-methylurapidil has been researched along with Hypertension, Pulmonary in 1 studies

Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.

Research Excerpts

ExcerptRelevanceReference
"In rats, injection of monocrotaline (MCT) causes pulmonary hypertension that leads to right ventricular failure."3.71Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats. ( Brodde, OE; Dhein, S; Giessler, C; Heinroth-Hoffmann, I; Leineweber, K; Seyfarth, T, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dhein, S1
Giessler, C1
Heinroth-Hoffmann, I1
Leineweber, K1
Seyfarth, T1
Brodde, OE1

Other Studies

1 other study available for 5-methylurapidil and Hypertension, Pulmonary

ArticleYear
Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2002, Volume: 365, Issue:2

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agon

2002